Physician

Farnaz Mohammadi, MD

According to 2025 Medicare claims, Farnaz Mohammadi, MD (NPI: 1245420140) practices nephrology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is LIMA MEMORIAL PROFESSIONAL CORPORATION (NPI: 1457474900; TIN: 341935236) and primary practice location at 45804-2800.

Mohammadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 495 traditional Medicare patients, billed 1,739 HCPCS/CPT codes, and received $148,415 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,742 prescription claims across 436 beneficiaries totaling $277,476 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 14 claims. Open Payments data shows 62 records totaling $1,420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $53,050 to $148,415. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,485 to $277,476. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $576 to $5,203.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	329	635	$53,050
2016	279	1,239	$102,440
2017	255	924	$75,954
2018	365	1,407	$98,532
2019	405	1,436	$100,879
2020	409	1,567	$106,026
2021	546	2,308	$162,927
2022	520	1,607	$141,325
2023	490	1,604	$135,095
2024	495	1,739	$148,415

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	107	$4,485
2016	38	117	$3,113
2017	64	316	$10,458
2018	143	698	$22,232
2019	226	1,472	$138,442
2020	273	2,174	$142,959
2021	378	2,509	$141,910
2022	376	2,617	$171,991
2023	385	2,701	$238,028
2024	436	2,742	$277,476

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$137
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	26	$348
2020	N/R	21	$403
2021	N/R	16	$269
2022	N/R	36	$1,763
2023	N/R	38	$2,425
2024	N/R	14	$4,923

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	58	60	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	38	90	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	225	370	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	125	347	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	279	422	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	40	1,260	$76,837
Farxiga	Dapagliflozin Propanediol	67	2,353	$42,974
Veltassa	Patiromer Calcium Sorbitex	44	1,576	$35,361
Jardiance	Empagliflozin	19	870	$16,931
Lanthanum Carbonate	Lanthanum Carbonate	25	810	$15,345

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$4,923

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,420	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Farnaz Mohammadi, MD?

Tedicare shows public-source Medicare data for Farnaz Mohammadi, MD (NPI 1245420140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Farnaz Mohammadi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Farnaz Mohammadi, MD?

Farnaz Mohammadi, MD is linked to LIMA MEMORIAL PROFESSIONAL CORPORATION (billing NPI 1457474900) in the available physician profile data.

Does Farnaz Mohammadi, MD have Open Payments data?

Farnaz Mohammadi, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.